[1] |
YANG Hongna, JI Ruijun, YU Kai, HE Yan, XU Lihua, WANG Yongjun.
Drug Adherence and Influencing Factors in Secondary Prevention of Ischemic Cerebrovascular Disease
[J]. Chinese Journal of Stroke, 2022, 17(11): 1227-1232.
|
[2] |
WU Qian, TAO Liyuan, CHEN Siqi, ZHONG Lianmei, LIU Liping, MI Donghua.
The Impact of Blood Glucose Fluctuation on Delayed Cerebral Ischemia and 30-day Mortality in Aneurysm
Subarachnoid Hemorrhage
[J]. Chinese Journal of Stroke, 2022, 17(08): 845-850.
|
[3] |
LU Jiajie, ZHAO Hongru.
Headache Phenotypes and Possible Mechanisms of Dural Arteriovenous Fistula
[J]. Chinese Journal of Stroke, 2022, 17(05): 461-465.
|
[4] |
ZHANG Yuyu, LIU Zhongzhong, LU Qingli, WANG Jing, LIU Pei, HOU Lina, ZHANG Na, LIN Xuemei, WANG Fang, WU Songdi.
The Relationship between eGFR and 1-Year Mortality in Young and Middle-aged Patients with Acute Stroke in Xi’an
[J]. Chinese Journal of Stroke, 2022, 17(01): 73-79.
|
[5] |
ZHANG Xin-Miao, WANG Chun-Juan, YANG Xin, GU Hong-Qiu, JIANG Ying-Yu, WANG Yi-Long, ZHAO Xing-Quan, LI Zi-Xiao, WANG Yong-Jun.
Safety of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Antithrombotic Therapy before Stroke Onset
[J]. Chinese Journal of Stroke, 2021, 16(11): 1110-1114.
|
[6] |
ZHANG Xue-Lei, MIAO Zhong-Rong, LIU Wei.
Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Patients with Large Infarct Core
[J]. Chinese Journal of Stroke, 2021, 16(09): 901-908.
|
[7] |
LIU Kai, WANG Yi-Long, LI Zi-Xiao, ZHANG Xin-Miao, GAO Yuan, HE Ming-Feng,GUO Xue-Fang, ZHAO Yan-Yan, HAN Xin-Sheng, ZHAO Ming-Zhi, YUE Jian-Hua, ZHANG Ping, ZHAO Jian-Hua,YAN Hong-Guang, MAO Xiang-Yi.
Inhospital Mortality and Related Influencing Factors in Acute Ischemic Stroke Patients Treated with Urokinase Intravenous Thrombolysis
[J]. Chinese Journal of Stroke, 2020, 15(10): 1078-1082.
|
[8] |
YUE Ting, LOU Ping, LU Qing-Shan.
Efficacy and Safety of Intravenous Thrombolysis Bridging Endovascular Therapy for Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2019, 14(12): 1232-1236.
|
[9] |
LIU Mao-Mao, WANG Dan-Dan, LI Zi-Xiao, ZHAO Xing-Quan.
Impact of Post-hemorrhage Seizures on 1-year Outcome in Patients with Spontaneous Supratentorial Intracerebral Hemorrhage
[J]. Chinese Journal of Stroke, 2019, 14(07): 660-664.
|
[10] |
YU Ruo-Mei, CAO Su-Han, MAO Bao-Yi, YANG Xi, TAO Meng-Xi, SUN Xiao-Pei.
Efficacy and Safety of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Mild#br#
Ischemic Stroke
[J]. Chinese Journal of Stroke, 2018, 13(09): 903-907.
|
[11] |
ZHENG Shui-Shun, WANG Wei-Wei, GUO Zhang, CHEN Hai-Ping, ZHANG Xiao-Feng.
Evaluation of Multidisciplinary Treatment of Ruptured Middle Cerebral Artery Aneurysms: A Single-center Retrospective Analysis
[J]. Chinese Journal of Stroke, 2018, 13(09): 944-949.
|
[12] |
Wang Yi-Long.
Strategy Selection of Antiplatelet Therapy for Ischemic Stroke in terms of the Ethnic Differences between Easterners and Westerners
[J]. Chinese Journal of Stroke, 2018, 13(05): 494-499.
|
[13] |
LU Yun-Kang, YANG Wu-Wei, WU Xian-Ru, LING Zheng, PENG Li-Ling, CHEN Bin.
[J]. Chinese Journal of Stroke, 2017, 12(09): 790-793.
|
[14] |
ZHAO Bo,WANG Jia-Wei.
Immune Mechanism and Progress of Immune-modulating Therapy after Ischemic Stroke
[J]. Chinese Journal of Stroke, 2017, 12(05): 426-431.
|
[15] |
ZUO Lian, LI Gang.
Non-thromolytic Effect of Tissue Plasminogen Activator
[J]. Chinese Journal of Stroke, 2017, 12(05): 462-467.
|